Confronto Tra Idrossiprolinuria E «Markers» Convenzionali Nel Monitoraggio Delle Metastasi Ossee Da Cancro Della Prostata

Bonadonna G. : Urinary hydroxyproline and calcium metabolism in patients with cancer. N. Engl. J. Med., 275; 298 (1966).

Bishop M , Fellow G. : Urine hydroxyproline excretion. A marker of bone metastases in prostatic carcinoma. Brit. J. Urol., 49; 711 (1977).

Bruce A. , Mahan D. , Sullivan L. , Golden-berg L. : The significance of prostatic acid phosphatase in adenocarcinoma of the prostate. J. Urol., 125; 357 (1981).

Cuschieri A. : Urinary hydroxyproline excretion in early and advanced breast cancer. A sequential study. Brit. J. Surg., 60; 800 (1973).

Gielen F. : Relevance of hydroxyproline excretion to bone metastases in breast cancer. Brit. J. Cancer, 34; 279 (1976).

Guzzo C. , Pachas W. , Pinals R. , Krant M. : Urinary hydrowyproline excretion in patients with cancer. Cancer, 24; 382 (1969).

Hopkins S. : Serial spot hydroxyproline/creatinine ratios in metastatic prostatic cancer. J. Urol., 129; 319 (1983).

Mooppan M. , Wax S. , Kim H. , Wang J. , Tobin M. : Urinary hydroxyproline excretion as a marker of osseous metastasis in carcinoma of the prostate. J. Urol., 123; 694 (1980).

Platt W. : Urine hydroxyproline excretion in metastatic cancer of bone. N. Engl. J. Med., 271; 287 (1964).

Pollen J. , Gerber K. , Ashburn W. , Schmidt J. : The value of nuclear bone imaging in advanced prostatic cancer. J. Urol., 125; 222 (1981).

Posen S. : Alkaline phosphatase. Ann. Intern. Med., 67; 183 (1967).

Powles T. : Early morning hydroxyproline excretion in patients with breast cancer. Cancer, 38; 2564 (1976).

Quinones G. : Will prostatic acid phosphatase determination by radioimmunoassay increase the diagnosis of early prostatic cancer? J. Urol., 125; 361 (1981).

Wajsman Z. : Clinical significance of serum alkaline phosphatase isoenzyme levels in advanced prostatic carcinoma. J. Urol., 119; 244 (1983).